Navin Fluorine FY26 Net Profit Rises 130% to ₹663.56 Cr
Navin Fluorine International reported strong financial results for FY26, with net profit rising 130% to ₹663.56 crore and revenue increasing 41% to ₹3,313.90 crore. Operating EBITDA surged 103% to ₹1,081.68 crore, driven by growth across HPP, Specialty Chemicals, and CDMO verticals. The company announced that its officials will meet analysts and investors in Singapore on June 9-10 and in Hong Kong on June 11-12, 2026.
*this image is generated using AI for illustrative purposes only.
Navin Fluorine International has reported its financial results for the fiscal year ended March 31, 2026. The company demonstrated strong performance across key financial metrics, driven by growth in its business verticals including HPP, Specialty Chemicals, and CDMO.
Financial Performance
For the full year FY26, the company’s net revenue from operations increased by 41% to ₹3,313.90 crore, up from ₹2,349.38 crore in FY25. The operating EBITDA surged by 103% to ₹1,081.68 crore, with the operating EBITDA margin expanding significantly to 32.6% from 22.7% in the previous year.
Profit After Tax (PAT) for FY26 rose by 130% to ₹663.56 crore compared to ₹288.60 crore in FY25. The operating Profit Before Tax (PBT) grew by 142% to ₹814.63 crore. On a standalone basis, net revenue from operations stood at ₹2,301.84 crore, with a PAT of ₹487.67 crore.
Quarterly Results
In the fourth quarter of FY26 (Q4FY26), the company reported a net revenue of ₹937.71 crore, a 34% increase year-on-year. The operating EBITDA for the quarter was ₹321.15 crore, an 80% rise, with a margin of 34.2%. PAT for Q4FY26 increased by 124% to ₹212.62 crore.
The following table summarizes the consolidated financial performance for FY26 and Q4FY26:
| Particulars (₹ Crs.) | Q4 FY26 | Q4 FY25 | Y-o-Y Change | FY26 | FY25 | Y-o-Y Change |
|---|---|---|---|---|---|---|
| Net Revenue from Operations | 937.71 | 700.94 | 34% | 3,313.90 | 2,349.38 | 41% |
| Operating EBITDA | 321.15 | 178.71 | 80% | 1,081.68 | 533.72 | 103% |
| Operating EBITDA Margin | 34.2% | 25.5% | 875 Bps | 32.6% | 22.7% | 992 Bps |
| Profit After Tax | 212.62 | 94.98 | 124% | 663.56 | 288.60 | 130% |
Business Verticals and Capex
Revenue growth was driven by all three business verticals. HPP revenues grew by 34%, Specialty Chemicals by 44%, and CDMO by 59% during FY26. The company is progressing with its ongoing capital expenditure projects, including additional HFC capacity and de-bottlenecking MPP capacity at Dahej.
Investor Meetings
The company announced that its officials will interact with analysts and investors on June 09, 10, 11, and 12, 2026. The meetings on June 09 and 10 will be held physically in Singapore with Jefferies, while the meetings on June 11 and 12 will be held in Hong Kong. The Fund Raising Committee was dissolved with effect from February 09, 2026.
Historical Stock Returns for Navin Fluorine International
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.09% | +3.37% | +11.79% | +19.29% | +66.94% | +122.73% |
How might Navin Fluorine's expanded HFC capacity at Dahej position it to capitalize on the global shift away from older refrigerants under the Kigali Amendment?
Given the CDMO segment's 59% revenue growth, which multinational pharma or agrochemical partnerships could drive the next phase of contract manufacturing expansion?
With the Fund Raising Committee dissolved in February 2026, how is Navin Fluorine planning to fund future capex beyond the current Dahej projects — through internal accruals or debt?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
